11/5
09:31 am
adap
Adaptimmune to Participate in Scientific and Medical Conferences this November and December [Yahoo! Finance]
Medium
Report
Adaptimmune to Participate in Scientific and Medical Conferences this November and December [Yahoo! Finance]
10/10
02:44 pm
adap
OTC Markets Hosts Virtual Investor Presentation with Adrian Rawcliffe, CEO of Adaptimmune Therapeutics, and Michael Kim, Senior Analyst at Zacks SCR [Yahoo! Finance]
Low
Report
OTC Markets Hosts Virtual Investor Presentation with Adrian Rawcliffe, CEO of Adaptimmune Therapeutics, and Michael Kim, Senior Analyst at Zacks SCR [Yahoo! Finance]
10/1
08:00 am
adap
Immuno-Oncology 360º Announces 2025 Keynotes and Featured Speakers for the 11th Annual Meeting in Boston
Low
Report
Immuno-Oncology 360º Announces 2025 Keynotes and Featured Speakers for the 11th Annual Meeting in Boston
10/1
07:30 am
adap
ReCode Announces Two Key Additions to Scientific Advisory Board
Low
Report
ReCode Announces Two Key Additions to Scientific Advisory Board
9/25
06:51 am
adap
Adaptimmune Therapeutics plc's (NASDAQ:ADAP) top owners are individual investors with 39% stake, while 28% is held by institutions [Yahoo! Finance]
Medium
Report
Adaptimmune Therapeutics plc's (NASDAQ:ADAP) top owners are individual investors with 39% stake, while 28% is held by institutions [Yahoo! Finance]
8/29
09:51 am
adap
Unlock the Full Potential of Cell and Gene Therapies: The 2024 GenScript Biotech Global Forum Heads to London
Neutral
Report
Unlock the Full Potential of Cell and Gene Therapies: The 2024 GenScript Biotech Global Forum Heads to London
8/15
08:14 am
adap
Adaptimmune Therapeutics (NASDAQ:ADAP) investors are sitting on a loss of 74% if they invested three years ago [Yahoo! Finance]
Medium
Report
Adaptimmune Therapeutics (NASDAQ:ADAP) investors are sitting on a loss of 74% if they invested three years ago [Yahoo! Finance]
8/14
02:59 pm
adap
Medigene AG (MDGEF) Q2 2024 Earnings Call Transcript [Seeking Alpha]
Low
Report
Medigene AG (MDGEF) Q2 2024 Earnings Call Transcript [Seeking Alpha]
8/13
11:04 pm
adap
Adaptimmune Therapeutics plc (NASDAQ: ADAP) was upgraded by analysts at StockNews.com from a "hold" rating to a "strong-buy" rating.
Low
Report
Adaptimmune Therapeutics plc (NASDAQ: ADAP) was upgraded by analysts at StockNews.com from a "hold" rating to a "strong-buy" rating.
8/13
02:22 pm
adap
Adaptimmune Therapeutics plc (NASDAQ: ADAP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
Low
Report
Adaptimmune Therapeutics plc (NASDAQ: ADAP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
8/13
09:53 am
adap
Thermo Fisher's (TMO) CDx Gets FDA's Nod for Synovial Sarcoma [Yahoo! Finance]
Medium
Report
Thermo Fisher's (TMO) CDx Gets FDA's Nod for Synovial Sarcoma [Yahoo! Finance]
8/12
11:47 am
adap
Adaptimmune Therapeutics plc (ADAP) Q2 2024 Earnings Call Transcript [Seeking Alpha]
Medium
Report
Adaptimmune Therapeutics plc (ADAP) Q2 2024 Earnings Call Transcript [Seeking Alpha]
8/12
07:44 am
adap
Adaptimmune GAAP EPS of $0.04 beats by $0.04, revenue of $128.2M beats by $83.44M [Seeking Alpha]
Medium
Report
Adaptimmune GAAP EPS of $0.04 beats by $0.04, revenue of $128.2M beats by $83.44M [Seeking Alpha]
8/9
08:13 am
adap
Adaptimmune leads in soft tissue sarcoma therapy with first TCR approval [Yahoo! Finance]
Low
Report
Adaptimmune leads in soft tissue sarcoma therapy with first TCR approval [Yahoo! Finance]
8/6
05:33 pm
adap
Sarcoma Therapeutics Market size is set to grow by USD 1.11 billion from 2024-2028, Patient assistance programs boost the market, Technavio [Yahoo! Finance]
Low
Report
Sarcoma Therapeutics Market size is set to grow by USD 1.11 billion from 2024-2028, Patient assistance programs boost the market, Technavio [Yahoo! Finance]
8/6
05:15 pm
adap
Sarcoma Therapeutics Market size is set to grow by USD 1.11 billion from 2024-2028, Patient assistance programs boost the market, Technavio
Neutral
Report
Sarcoma Therapeutics Market size is set to grow by USD 1.11 billion from 2024-2028, Patient assistance programs boost the market, Technavio